CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) $ in Millions		3 Months Ended
		Sep. 30, 2023	Sep. 30, 2022
Net Sales		$ 21,871	$ 20,612
Cost of Products Sold		10,501	10,846
Selling, General and Administrative Expense		5,604	4,827
Operating Income		5,767	4,939
Interest Expense		(225)	(123)
Interest Income		128	42
Other Non-operating Income/(Loss), Net		132	139
Earnings/(Loss) from Continuing Operations Before Income Taxes		5,802	4,997
Income Taxes on Continuing Operations		1,246	1,034
Net Earnings		4,556	3,963
Net Income (Loss) Attributable to Noncontrolling Interest		35	24
Net Income (Loss) Attributable to Parent		$ 4,521	$ 3,939
Basic Net Earnings Per Common Share
Basic Net Earnings/(Loss) Per Common Share	[1],[2]	$ 1.89	$ 1.62
Diluted Net Earnings Per Common Share
Diluted Net Earnings/(Loss) Per Common Share	[1],[2]	$ 1.83	$ 1.57

[1] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

[2] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.